Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan

-Samsung Bioepis Co., Ltd. today announced the launch of Ustekinumab BS 45 mg Syringe for S.C. ...

Original source: Antara News